Sugi Predict

Sugi Predict / Compounds / SCHEMBL16150299

SCHEMBL16150299

SCHEMBL16150299

COCCOCCOCCOc1cc(OC)cc([N+](=O)[O-])c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.49
▸ LMNA P02545 5/20 0.49
▸ MAPT P10636 4/20 0.47
▸ HPGD P15428 2/20 0.47
▸ KMT2A Q03164 3/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ PTGS1 P23219 1/20 0.43
▸ PTGS2 P35354 1/20 0.43
▸ S1PR4 O95977 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ CHRNB2 P17787 1/20 0.40
▸ CHRNA4 P43681 1/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ HTT P42858 1/20 0.39
▸ ALOX5 P09917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16106244 1.00 ALDH1A1 (0.49) ALDH1A1LMNAMAPTHPGDKMT2A
SCHEMBL16106495 1.00 ALDH1A1 (0.49) ALDH1A1LMNAMAPTHPGDKMT2A
SCHEMBL15720675 0.88 ALDH1A1 (0.47) ALDH1A1LMNAMAPTHPGDKMT2A
SCHEMBL15720161 0.86 CHRNB2 (0.56) ALDH1A1LMNAMAPTHPGDKMT2A
SCHEMBL16106440 0.85 LMNA (0.44) ALDH1A1LMNAMAPTHPGDKMT2A
SCHEMBL15720699 0.85 S1PR4 (0.56) ALDH1A1LMNAMAPTHPGDKMT2A
SCHEMBL15720774 0.85 CHRNB4 (0.51) ALDH1A1LMNAMAPTHPGDKMT2A
SCHEMBL16106578 0.85 MEN1 (0.45) ALDH1A1LMNAMAPTHPGDKMT2A
SCHEMBL19434603 0.85 ALDH1A1 (0.44) ALDH1A1LMNAMAPTHPGDKMT2A
SCHEMBL15721030 0.85 VCAM1 (0.51) ALDH1A1LMNAMAPTHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2981535-B1 UREA DERIVATIVES USEFUL AS KINASE INHIBITORS TOPIVERT PHARMA LTD (GB) 2020-12-16 — — EP disclosed
US-10435361-B2 Kinase inhibitors TOPIVERT PHARMA LIMITED (GB) 2019-10-08 — — US disclosed
US-20180044288-A1 KINASE INHIBITORS OXULAR ACQUISITIONS LIMITED (GB) 2018-02-15 — — US disclosed
US-9890185-B2 Urea derivatives useful as kinase inhibitors RESPIVERT LIMITED (GB) 2018-02-13 — — US disclosed
US-9790174-B2 Kinase inhibitors RESPIVERT LIMITED (GB) 2017-10-17 — — US disclosed
US-9771353-B2 Kinase inhibitors based upon N-alkyl pyrazoles TOPIVERT PHARMA LIMITED (GB) 2017-09-26 — — US disclosed
EP-3201189-A1 N-PHENYL-3-QUINAZOLIN-6-YL-BENZAMIDE DERIVATIVES AS P38 KINASE INHIBITORS Respivert Limited (GB) 2017-08-09 — — EP disclosed
US-20170209445-A1 KINASE INHIBITORS RESPIVERT LIMITED (GB) 2017-07-27 — — US disclosed
EP-2981534-B1 KINASE INHIBITORS BASED UPON N-ALKYL PYRAZOLES TOPIVERT PHARMA LTD (GB) 2017-07-19 — — EP disclosed
US-20160376232-A1 KINASE INHIBITORS OXULAR ACQUISITIONS LIMITED (GB) 2016-12-29 — — US disclosed
US-20160318958-A1 UREA DERIVATIVES USEFUL AS KINASE INHIBITORS OXULAR ACQUISITIONS LIMITED (GB) 2016-11-03 — — US disclosed
EP-3083604-A1 UREA DERIVATIVES USEFUL AS KINASE INHIBITORS Respivert Limited (GB) 2016-10-26 — — EP disclosed
WO-2016051186-A1 N-PHENYL-3-QUINAZOLIN-6-YL-BENZAMIDE DERIVATIVES AS P38 KINASE INHIBITORS RESPIVERT LIMITED (GB) 2016-04-07 — — WO disclosed
US-20160039797-A1 KINASE INHIBITORS BASED UPON N-ALKYL PYRAZOLES OXULAR ACQUISITIONS LIMITED (GB) 2016-02-11 — — US disclosed
EP-2981534-A1 KINASE INHIBITORS BASED UPON N-ALKYL PYRAZOLES Topivert Pharma Limited (GB) 2016-02-10 — — EP disclosed
EP-2981535-A1 UREA DERIVATIVES USEFUL AS KINASE INHIBITORS Respivert Limited (GB) 2016-02-10 — — EP disclosed
WO-2015092423-A1 UREA DERIVATIVES USEFUL AS KINASE INHIBITORS RESPIVERT LIMITED (GB) 2015-06-25 — — WO disclosed
US-20150166483-A1 KINASE INHIBITORS RESPIVERT LTD (GB) 2015-06-18 — — US disclosed
WO-2014162121-A1 KINASE INHIBITORS BASED UPON N-ALKYL PYRAZOLES TOPIVERT PHARMA LIMITED (GB) 2014-10-09 — — WO disclosed
WO-2014162126-A1 UREA DERIVATIVES USEFUL AS KINASE INHIBITORS RESPIVERT LIMITED (GB) 2014-10-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160318958-A1 UREA DERIVATIVES USEFUL AS KINASE INHIBITORS SYK, UACA, YES1 ALDH1A1 2713/4885LMNA 3198/4885MAPT 2541/4885
US-20180044288-A1 KINASE INHIBITORS SYK, LYN, BTK ALDH1A1 4408/4885LMNA 3020/4885MAPT 3802/4885
US-20160376232-A1 KINASE INHIBITORS LYN, SYK, LCK ALDH1A1 3120/4885LMNA 3949/4885MAPT 4010/4885
US-20170209445-A1 KINASE INHIBITORS SYK, BTK, LCK ALDH1A1 4032/4885LMNA 4711/4885MAPT 3137/4885
US-20150166483-A1 KINASE INHIBITORS LCK, SYK, FYN ALDH1A1 4277/4885LMNA 4839/4885MAPT 2895/4885
US-10435361-B2 Kinase inhibitors SYK, LYN, BTK ALDH1A1 4408/4885LMNA 3020/4885MAPT 3802/4885
US-20160039797-A1 KINASE INHIBITORS BASED UPON N-ALKYL PYRAZOLES SYK, LCK, BTK ALDH1A1 4281/4885LMNA 4798/4885MAPT 3384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.